ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

London-based AI drug discovery firm Isomorphic Labs raised $5 billion in a Series C round co-led by Greenoaks and Sequoia Capital. New investors include Andreessen Horowitz, Alphabet, Thrive Capital, MGX, GV, CapitalG, Temasek and UK Sovereign AI Fund. The funding supports clinical trials and expanding its proprietary IsoDDE engine for treating cancer and immune disorders.
Tap to vote and see what everyone thinks.
Summary by ByteBrief